Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis (Q57108591)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

title

Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

Guilherme M Campos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

author name string

Guilherme S Mazzini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

Jad Khoraki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

Matthew G Browning

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

Dayanjan Wijesinghe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

Luke Wolfe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

Richard R Gurski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

language of work or name

English

0 references

publication date

11 September 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

Journal of Gastrointestinal Surgery

22 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

page(s)

51-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

22 April 2020

cites work

1 reference

12 December 2020

The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor alpha-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal beta-oxidation enzymes a

1 reference

12 December 2020

Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor

1 reference

12 December 2020

Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of L

1 reference

12 December 2020

Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling

1 reference

12 December 2020

NAFLD, obesity, and bariatric surgery

1 reference

12 December 2020

Non-alcoholic steatohepatitis and metabolic syndrome

1 reference

12 December 2020

The Randle cycle revisited: a new head for an old hat.

1 reference

12 December 2020

Regulation of bile acid and cholesterol metabolism by PPARs

1 reference

12 December 2020

The impact of bariatric surgery on nonalcoholic steatohepatitis

1 reference

12 December 2020

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

12 December 2020

NCBI GEO: archive for functional genomics data sets--update

1 reference

12 December 2020

Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity

1 reference

12 December 2020

Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial

1 reference

12 December 2020

FXR is a molecular target for the effects of vertical sleeve gastrectomy

1 reference

12 December 2020

Integrated physiology and systems biology of PPARα

1 reference

12 December 2020

The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice

1 reference

12 December 2020

PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

1 reference

12 December 2020

Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients

1 reference

12 December 2020

Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?

1 reference

12 December 2020

The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review.

1 reference

12 December 2020

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

1 reference

12 December 2020

Bile Acids Increase Independently From Hypocaloric Restriction After Bariatric Surgery

1 reference

12 December 2020

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

1 reference

12 December 2020

Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial

1 reference

12 December 2020

The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery

1 reference

12 December 2020

Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function.

1 reference

12 December 2020

Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome

1 reference

12 December 2020

Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

Regulation of Liver Energy Balance by the Nuclear Receptors Farnesoid X Receptor and Peroxisome Proliferator Activated Receptor α.

1 reference

12 December 2020

miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice

1 reference

12 December 2020

Targeting nuclear receptors for the treatment of fatty liver disease

1 reference

12 December 2020

Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin

1 reference

12 December 2020

Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice

1 reference

12 December 2020

Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial

1 reference

12 December 2020

Bile acid physiology as the potential driver for the sustained metabolic improvements with bariatric surgery

1 reference

12 December 2020

Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).

1 reference

12 December 2020

Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH.

1 reference

12 December 2020

Concurrent miR-21 suppression and FXR activation as a mechanism of improvement in nonalcoholic fatty liver disease.

1 reference

12 December 2020

10.1007/S11605-018-3938-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30206765 AND SRC:MED&resulttype=core&format=json

22 April 2020

1 reference